<!DOCTYPE html><html lang="en"><head><meta name="generator" content="Scully 0.0.0">
  <meta charset="utf-8">
  <title>NgxGardSkully 123</title>
  <base href="/">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <link rel="icon" type="image/x-icon" href="favicon.ico">
<link rel="stylesheet" href="styles.4cdd1989b7928c8b693d.css"><style>body,html{overflow-x:hidden}@media (max-width:991.98px){.offcanvas-collapse{position:fixed;top:56px;bottom:0;left:100%;width:100%;padding-right:1rem;padding-left:1rem;overflow-y:auto;visibility:hidden;background-color:#343a40;transition:transform .3s ease-in-out,visibility .3s ease-in-out}.offcanvas-collapse.open{visibility:visible;transform:translateX(-100%)}}.nav-scroller{position:relative;z-index:2;height:2.75rem;overflow-y:hidden}.nav-scroller .nav{display:flex;flex-wrap:nowrap;padding-bottom:1rem;margin-top:-1px;overflow-x:auto;color:hsla(0,0%,100%,.75);text-align:center;white-space:nowrap;-webkit-overflow-scrolling:touch}.nav-underline .nav-link{padding-top:.75rem;padding-bottom:.75rem;font-size:.875rem;color:#6c757d}.nav-underline .nav-link:hover{color:#007bff}.nav-underline .active{font-weight:500;color:#343a40}.text-white-50{color:hsla(0,0%,100%,.5)}.bg-purple{background-color:#6f42c1}.lh-100{line-height:1}.lh-125{line-height:1.25}.lh-150{line-height:1.5}.splitter{margin-left:20px;margin-right:20px;display:inline-block;font-size:20px;transform:scaleX(.3)}.banner{background-color:#1b5b76;height:116px;background-image:url(https://rarediseases.info.nih.gov/content/images/banner-touch-diseases.jpg);background-repeat:no-repeat;background-position:100%}.search-ct{top:40px;left:30px}.footer{background:#d3d3d3;height:230px}.footer-links{padding-top:20px}.footer-text{margin-top:30px;text-align:center}.input-group-text{cursor:pointer}</style><style></style><script>window['ScullyIO']='generated';</script><script>window.ScullyIOAngularDisabled = true;</script></head>
<body scully-version="0.0.0">
  <app-root ng-version="10.0.14"><nav class="navbar navbar-dark sticky-top bg-dark flex-md-nowrap p-0 shadow"><span class="shrink-width"><ul class="navbar-nav px-3 list-inline"><li class="nav-item text-nowrap list-inline-item"><span href="#" class="nav-link">U.S. Department of Health &amp; Human Services <span class="splitter"> &gt; </span> National Institutes of Health <span class="splitter"> &gt; </span> NCATS</span></li></ul></span></nav><div class="shrink-width"><div class="nav-scroller bg-white shadow-sm justify-content-center"><nav class="nav nav-underline"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases">Diseases</a><a routerlink="/help" routerlinkactive="active" class="nav-link" href="/help">Guides</a><a routerlink="/about" routerlinkactive="active" class="nav-link" href="/about">News</a><a routerlink="/glossary" routerlinkactive="active" class="nav-link" href="/glossary">About GARD</a><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases">En Espanõl</a></nav></div><form novalidate="" class="ng-untouched ng-pristine ng-valid"><div class="banner"><div class="col-md-6 search-ct"><div class="input-group mb-3"><input formcontrolname="search" type="text" placeholder="Search for Diseases, Organizations, News and More..." aria-label="Search for Diseases, Organizations, News and More..." aria-describedby="basic-addon2" class="form-control ng-untouched ng-pristine ng-valid"><span class="input-group-text">GO</span></div></div></div></form><div class="container-fluid"><router-outlet></router-outlet><app-disease-details><div class="row"><div class="col-md-3"><nav><div class="sidebar-sticky pt-3"><ul class="nav flex-column"><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> Browse A-Z </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> Find Diseases By Category </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> List of FDA Orphan Drugs </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> GARD Information Navigator </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> FAQs About Rare Diseases </a></li></ul></div></nav></div><main role="main" class="col-md-9"><div class="d-flex justify-content-between flex-wrap flex-md-nowrap align-items-center pt-3 pb-2 mb-3 border-bottom"><h1 class="h2">Disease # 10335 - Mucopolysaccharidosis type I</h1></div><div><p><b>Other Names: </b>MPS 1, Attenuated MPS I (subtype, includes Hurler-Scheie and Scheie syndrome), Severe MPS I (subtype, also known as Hurler syndrome), Hurler syndrome (subtype), Hurler-Scheie syndrome (subtype), Scheie syndrome (subtype) formerly known as Mucopolysaccharidosis type V), Alpha-L-Iduronidase deficiency, IDUA deficiency, MPS I</p><p><b>Categories: </b><span> Newborn Screening</span><!----></p><p><b>This disease is grouped under: </b>Hurler syndrome</p><p><b>Summary: </b><span><strong>Mucopolysaccharidosis type I (MPS I)</strong> is a condition that affects many parts of the body. It is a progressively debilitating disorder; however, the rate of progression varies among affected individuals.&nbsp;MPS I&nbsp;is caused by mutations in the <em><a href="http://ghr.nlm.nih.gov/gene/IDUA" target="_blank">IDUA</a></em> gene. These mutations lead to reduced levels or the complete lack of&nbsp;the IDUA <a href="http://www.genome.gov/glossary.cfm?key=enzyme" target="_blank">enzyme</a>. Without the proper amount of this enzyme, large sugar molecules called glycosaminoglycans (GAGs) accumulate within cells called lysosomes. This causes the lysosomes to increase in size, causing many different&nbsp;organs and tissues of the body to become enlarged. This leads to the medical problems seen in the condition.[558][10556]&nbsp;<br>
<br>
MPS I was once divided into three separate syndromes: Hurler syndrome, Hurler-Scheie syndrome, and Scheie syndrome, listed from most to least severe. Because no biochemical differences have been identified and the clinical findings overlap, the condition is now divided into two subtypes, severe MPS I and attenuated MPS I.[558][10556] People with severe MPS I typically have an earlier onset of symptoms, a decline in intellectual function, and a shorter lifespan. Although there is no cure for MPS I,&nbsp;<a href="http://www.nlm.nih.gov/medlineplus/ency/article/003009.htm" target="_blank">bone marrow transplant</a> and enzyme replacement therapy are treatment options that may help manage the symptoms of this condition.[558]</span></p><div><b>Organizations: </b><ul><li><span><a href="org.url">Canadian Society for Mucopolysaccharide and Related Diseases Inc. (Canadian MPS Society)</a></span><br><span>#218-2055 Commercial Drive </span><br><span> , </span><br><!----><!----></li><li><span><a href="org.url">National MPS Society</a></span><br><span>P.O. Box 14686 </span><br><span>Durham NC, 27709-4686</span><br><!----><!----></li><li><span><a href="org.url">Society for Mucopolysaccharide (MPS) Diseases</a></span><br><span>MPS House Repton Place White Lion Road</span><br><span> , </span><br><!----><!----></li><!----></ul></div><div><b>Learn More</b><ul><li><span><a href="http://www.omim.org/607015" target="_blank">Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br>
</span></li><li><span><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;Cmd=DetailsSearch&amp;Term=(%22mucopolysaccharidosis+i%22%5BMeSH+Terms%5D+OR+%22mucopolysaccharidosis+i%22%5BAll+Fields%5D+OR+%22mucopolysaccharidosis+type+i%22%5BAll+Fields%5D)+AND+(hasabstract%5Btext%5D+AND+%222006%2F07%2F17%22%5BPDat%5D+%3A+%222008%2F07%2F15%22%5BPDat%5D+AND+%22humans%22%5BMeSH+Terms%5D+AND+English%5Blang%5D)" target="_blank">PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Mucopolysaccharidosis type I. Click on the link to view a sample search on this topic.</span></li><li><span><a href="http://www.clinicaltrials.gov/ct2/results?cond=%22Mucopolysaccharidosis+type+I%22" target="_blank">ClinicalTrials.gov</a> lists trials that are related to Mucopolysaccharidosis type I. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br>
<br>
<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em></span></li><li><span>The <a href="https://www.asgct.org/education" target="_blank">American Society of Gene &amp; Cell Therapy</a> provides information on the treatment of genetic diseases.</span></li><li><span><a href="https://www.babysfirsttest.org/newborn-screening/conditions/mucopolysaccharidosis-type-i" target="_blank">Baby's First Test</a> is the nation's newborn screening education center for families and providers. This site provides information and resources about screening at the local, state, and national levels and serves as the Clearinghouse for newborn screening information.</span></li><li><span>The&nbsp;<a href="https://www.rarediseasesnetwork.org/ldn" target="_blank">Lysosomal Disease Network</a>&nbsp;is a team of doctors, nurses, research coordinators, and research labs throughout the U.S., working together to improve the lives of people with this condition through research. The&nbsp;Lysosomal Disease Network&nbsp;has a registry for patients who wish to be contacted about clinical research opportunities.<br></span></li><li><span>To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href="http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx" target="_blank">American College of Medical Genetics</a> and the&nbsp;<a href="https://www.findageneticcounselor.com/" target="_blank">National Society of Genetic Counselors</a>. If you need additional help, <a href="https://rarediseases.info.nih.gov/about-gard/contact-gard">contact a GARD Information Specialist</a>. You can also&nbsp;<a href="https://ghr.nlm.nih.gov/primer#consult" target="_blank">learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.</span></li><li><span>The <a href="https://rarediseases.org/rare-diseases/mucopolysaccharidosis-type-i/" target="_blank">National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br>
</span></li><li><span><a href="http://www.nlm.nih.gov/medlineplus/ency/article/001204.htm" target="_blank">MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.
<br>
</span></li><li><span>The <a href="https://www.ninds.nih.gov/Disorders/All-Disorders/Mucopolysaccharidoses-Information-Page" target="_blank">National Institute of Neurological Disorders and Stroke</a> (NINDS) collects and disseminates research information related to neurological disorders. Click on the link to view information on&nbsp;this topic.</span></li><li><span>The <a href="https://secure.ssa.gov/apps10/poms.nsf/lnx/0423022415" target="_blank">Social Security Administration</a> has included this condition in their Compassionate Allowances Initiative. This initiative speeds up the processing of disability claims for applicants with certain medical conditions that cause severe disability. More information about <a href="http://www.ssa.gov/compassionateallowances/index.htm" target="_blank">Compassionate Allowances</a> and <a href="https://www.ssa.gov/benefits/disability/" target="_blank">applying for Social Security disability</a> is available online.</span></li><li><span><a href="http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=579" target="_blank">Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br>
</span></li><li><span><a href="http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&amp;part=mps1" target="_blank">GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br>
</span></li><li><span>Coletti HY, Aldenhoven M, Yelin K, Poe MD, Kurtzberg J, and Escolar ML. <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4375128/" target="_blank">Long-Term Functional Outcomes of Children with Hurler Syndrome Treated with Unrelated Umbilical Cord Blood Transplantation</a> JIMD Rep. 2015; 20: 77–86.</span></li><li><span>The <a target="_blank" href="http://www.med.upenn.edu/orphandisease/rare-disease-overview.shtml#MPSI ">Orphan Disease Center: MPS I Pilot Grant Program</a> presents a request for applications (RFA) to support research on the development of improved therapies for people with syndromes due to MPS I including Hurler, Hurler-Scheie and Scheie. All individuals holding a faculty-level appointment at an academic or non-profit institution are eligible to respond to this RFA. Grants will be awarded for an initial period of 1 to 2 years at $150,000 direct costs per year (up to 10% indirect costs allowable); funding for a second year is predicated by adequate progress during year 1 and availability of funding. All applicants must first submit a letter of Interest (LOI) to be reviewed for consideration of a full application submission. LOIs are due no later than Monday, February 29, 2016 at 5pm (EST).</span></li><li><span>The <a href="https://monarchinitiative.org/disease/DOID:12802" target="_blank">Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch’s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.</span></li><!----></ul></div></div></main><!----></div></app-disease-details><!----></div></div><div class="footer"><div class="shrink-width"><div class="footer-links row align-items-center"><div class="col"><a href="/" target="_self">GARD Home</a></div><div class="col"><a href="http://ncats.nih.gov/" target="_blank">NCATS Home</a></div><div class="col"><a href="/sitemap" target="_self">Site Map</a></div><div class="col"><a href="/glossary" target="_self">Browse Glossary A-Z</a></div><div class="col"><a href="/pages/36/privacy-notice" target="_self">Privacy Notice</a></div><div class="col"><a href="/pages/37/disclaimer" target="_self">Disclaimer</a></div><div class="col"><a href="/pages/38/accessibility" target="_self">Accessibility</a></div><div class="col"><a href="/pages/39/foia" target="_self">FOIA </a></div><div class="col"><a href="http://oig.hhs.gov/" target="_blank">OIG</a></div></div><div class="footer-text"><p> If you have problems viewing PDF files, download the latest version of <a target="_blank" href="https://get.adobe.com/reader/" class="footer-links">Adobe Reader</a></p><p> For <a f="http://edi.nih.gov/consulting/language-access-program/about" target="_blank" title="Read the plan" class="ext">language access</a> assistance, contact the <a href="mailto: info@ncats.nih.gov" title="E - mail Public Information Officer" class="footer-links">NCATS Public Information Officer</a></p><p> Genetic and Rare Diseases Information Center (GARD) - PO Box 8126, Gaithersburg, MD 20898-8126 - Toll-free: 1-888-205-2311 </p></div></div></div></app-root>

<script src="js/custom.js"></script>

</body></html>